A clinical trial for an antibody-drug conjugate: an open-label, multicenter, phase i dose escalation study of MEN1309, a SD205 antibody-drug conjugate, in patients with cd205-positive metastatic solid tumors and non-hodkin lymphoma..

Tesis doctoral: Tesina (TFM)

Fecha de lectura2019
Idioma originalInglés
Institución de lectura
  • Universitat Autònoma de Barcelona (UAB)
SupervisorCaridad Pontes Garcia (Director/a)

Citar esto

'